BYCRF yields 2.34% · JNJ yields 2.13%● Live data
📍 BYCRF pulled ahead of the other in Year 1
Combined, BYCRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BYCRF + JNJ for your $10,000?
BayCurrent Consulting, Inc. provides consulting services in Japan. The company provides engaged in designing and implementing strategy/business strategy, globalization, m&a/jv/alliances, innovation/new business development, turn-around, innovation/new business development, overseas expansion, global resource utilization, global governance design, change towards capturing inbound demand, marketing and sales strategy, and business due diligence.It offers DX-based high level planning, digital department launch, blockchain utilization, business model DX, designing thinking/agile operations, digital marketing, AI/IoT implementation, DX strategy/roadmap formulation, digital human resource development, fintech/insurtech, operation DX, and lean start-ups services. Additionally, the company provides procurement cost reduction, business process re-engineering, supply chain management, customer relationship management, risk management, value chain transformation, governance/management design, operation reform/standardization, and leadership training services. Further, it offers IT strategy, IT governance, IT cost optimization, IT organizational improvement, IT talent development, PMO, IT architecture, system design/ development, and IT asset evaluation services. The company serves financial, high-tech/telecommunication, media/entertainment, industrial/distribution/retail, health care, energy, and public sector industries. BayCurrent Consulting, Inc. was founded in 1998 and is based in Tokyo, Japan.
Full BYCRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.